Highlights and Quick Summary
- Total non-current liabilities for the quarter ending October 31, 2022 was $27.1 Million (a -13.3% decrease compared to previous quarter)
- Year-over-year quarterly Total non-current liabilities increased by 10822.29%
- Annual Total non-current liabilities for 2022 was $31.3 Million (a 5.0% increase from previous year)
- Annual Total non-current liabilities for 2021 was $29.8 Million (a 19024.63% increase from previous year)
Visit stockrow.com/BCTX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total non-current liabilities of BRIACELL THERAP
Most recent Total non-current liabilitiesof BCTX including historical data for past 10 years.Interactive Chart of Total non-current liabilities of BRIACELL THERAP
BRIACELL THERAP Total non-current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $27.14 | $31.31 | $0.28 | $0.25 | $31.31 |
| 2021 | $0.33 | $29.82 | $6.89 | $0.15 | $29.82 |
| 2020 | $0.15 | $0.16 | – | – | $0.16 |
Business Profile of BRIACELL THERAP
Sector: Healthcare
Industry: Biotechnology